- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05231577
7.5F Versus 9.2F Flexible Ureteroscopy for the Treatment of 1-2cm Renal Calculi on Postoperative Infection
7.5F Versus 9.2F Flexible Ureteroscopy for the Treatment of 1-2cm Renal Calculi on Postoperative Infection:An International Multicenter Randomized Controlled Trial
Ureteroscopic lithotripsy (RIRS) is the first-line treatment for 1-2 cm upper urinary tract stones, and the stone clearance rate can reach 81.4% - 92.5%. Fever after RIRS is the most common infection after RIRS, and its incidence is up to 20%. The incidence rate of systemic inflammatory response syndrome is 6.5% - 10.3%, sepsis 0.1% - 4.3%, with the infection progressed. If there is no timely and effective intervention in the early stage of urogenic sepsis, it can progress to septic shock, and the mortality can be as high as 30% - 40%. High intrarenal pressure is an important risk factor for postoperative infection. American Urological Association (AUA) guidelines point out that controlling intrarenal pressure at an appropriate level is particularly important to prevent postoperative infection.
The use of ureteroscopic sheath in ureteroscopic surgery can effectively reduce the intrarenal pressure, which is an important measure to reduce the incidence of postoperative infection. Theoretically, the larger the space, the better the reflux effect and the lower the incidence of postoperative infection. The study showed that the incidence of ureteral sheath infection was significantly lower than that of ureteral sheath infection after operation. When using the same caliber ureteroscopic sheath, use a smaller caliber ureteroscopy to increase the space between the ureteroscopy and the ureteral sheath, promote reflux, reduce intrarenal pressure and reduce the incidence of postoperative infection. However, there is still a lack of relevant research on the effect of different caliber ureteroscopy in the treatment of renal calculi on postoperative infection.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Guangdong,China
-
Guangzhou, Guangdong,China, China, 510230
- Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
-
Contact:
- Guohua Zeng, Ph.D & MD
- Phone Number: +8613802916676
- Email: gzgyzgh@vip.sina.com
-
Contact:
- Wen Zhong, Ph.D & MD
- Phone Number: +8613631320020
- Email: gzgyzhongwen@163.com
-
Sub-Investigator:
- Wen Zhong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Agree to receive ureteroscopy
- Aged 18-70 years. 3.1-2cm kidney stones
Exclusion Criteria:
- Combined with middle and lower ureteral calculi, surgical operation other than RIRS is required;
- Patients with abnormal anatomical structure, ureteral stenosis and urinary diversion, such as ectopic kidney, horseshoe kidney and duplicate kidney;
- Patients who have undergone nephrostomy;
- Severe cardiopulmonary insufficiency;
- Pregnant women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Patients in Group 0 undergo 7.5fr ultra-fine ureteroscopy
|
The patient placed the lithotomy position, placed the ureteroscope to explore the affected ureter, retrogradely placed the guide wire, and placed the 12 / 14fr ureteral sheath under X-ray monitoring until the affected ureter was close to the outlet of the renal pelvis.
Group 1 patients used 7.5fr ultra-fine ureteroscopy
|
|
Experimental: Experimental: Patients in Group 2 undergo 9.2fr ureteroscopy
|
The patient placed the lithotomy position, placed the ureteroscope to explore the affected ureter, retrogradely placed the guide wire, and placed the 12 / 14fr ureteral sheath under X-ray monitoring until the affected ureter was close to the outlet of the renal pelvis.
Group 2 patients used 9.2fr Ureteroscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative fever
Time Frame: ≤ 1month postoperatively
|
Postoperative fever was defined as armpit temperature ≥38C
|
≤ 1month postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stone free rate (SFR)
Time Frame: 1 month after removing the pigtail stent
|
2mm Non-contrast CT is obtained for all patients at one month after removing the pigtail stent to evaluate the final SFR.
Stone-free status are defined as either the absence of any residual stone fragments or the presence of clinically insignificant residual stone fragments in the kidney which were definded as ≤ 4mm, asymptomatic, non-obstructive and non-infectious stone particles
|
1 month after removing the pigtail stent
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCT(2022)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stones
-
Calyxo, Inc.Not yet recruitingUrolithiasis | Kidney Stones | Renal Stones | Stones, Kidney
-
Indiana Kidney Stone InstituteUniversity of Washington; VA Puget Sound Health Care SystemCompleted
-
Omeros CorporationCompletedUrinary Calculi | Renal Calculi | Kidney Stones | Urinary Stones | Urinary Tract StonesUnited States
-
Mayo ClinicCompletedKidney Calculi | Nephrolithiasis | Kidney Stones | Renal StonesUnited States, Canada
-
Calyxo, Inc.RecruitingUrolithiasis | Kidney Stones | Renal Stones | Stones, KidneyUnited States
-
United States Naval Medical Center, San DiegoUnknown
-
AdventHealthNot yet recruitingKidney Calculi | Kidney Stones | Renal Stone Disease | Refractory Kidney StonesUnited States
-
University of British ColumbiaPercutaneous Systems, Inc.Completed
-
Robert SworWilliam Beaumont HospitalsCompletedKidney Stones | Ureteral StonesUnited States
Clinical Trials on 7.5fr ultra-fine ureteroscopy
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery SystemsUnited States
-
Becton, Dickinson and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
Peking Union Medical College HospitalRecruitingAutoimmune PancreatitisChina
-
Becton, Dickinson and CompanyCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1United States
-
University of AlbertaCompletedLymphoma | Pancreas Adenocarcinoma | Pancreas Neoplasms | Gastrointestinal Stromal TumorCanada
-
Becton, Dickinson and CompanyTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Foundation for Liver ResearchCook Ireland, Ltd.CompletedPancreatic Masses | Lymph NodesFrance, Sweden, Israel, Belgium, Australia, United States, Italy, Japan, Netherlands, Spain
-
HTL-Strefa S.A.CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
-
Cairo UniversityUnknownCandida Infection | Denture Stomatitis